Bruno Gagnon
Corporate Officer/Principal bei OPTHEA LIMITED
Aktive Positionen von Bruno Gagnon
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| OPTHEA LIMITED | Corporate Officer/Principal | 01.07.2022 | - |
Karriereverlauf von Bruno Gagnon
Ehemalige bekannte Positionen von Bruno Gagnon
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| BIOMARIN PHARMACEUTICAL INC. | Geschäftsführer | - | - |
| EIDOS THERAPEUTICS, INC. | Geschäftsführer | - | - |
Ausbildung von Bruno Gagnon
| University of Montréal | Graduate Degree |
| Université Laval | Undergraduate Degree |
Statistik
International
| Vereinigte Staaten | 3 |
| Kanada | 3 |
| Australien | 2 |
Operativ
| Chief Operating Officer | 2 |
| Corporate Officer/Principal | 1 |
| Graduate Degree | 1 |
Sektoral
| Health Technology | 4 |
| Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| OPTHEA LIMITED | Health Technology |
| BIOMARIN PHARMACEUTICAL INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Eidos Therapeutics, Inc.
 Eidos Therapeutics, Inc. BiotechnologyHealth Technology Eidos Therapeutics, Inc. focuses on addressing the large and growing unmet need in diseases caused by transthyretin (TTR) amyloidosis (ATTR). Its product include the AG10, an orally-administered small molecule designed to potently stabilize TTR, suggesting a treatment with the potential to halt the progression of ATTR. The company was founded by Graef Isabella and Alhamadsheh Mamoun on August 6, 2013 and is headquartered in San Francisco, CA. | Health Technology |
- Börse
- Insiders
- Bruno Gagnon
- Erfahrung
